Cargando…

Extraordinary increase in West Nile virus cases and first confirmed human Usutu virus infection in Hungary, 2018

BACKGROUND: During the 2018 WNV transmission season, similarly to other endemic areas in Europe, a large number of human West Nile virus (WNV) infections were reported in Hungary. AIMS: We summarise the epidemiological and laboratory findings of the 2018 transmission season and expand experiences in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagy, Anna, Mezei, Eszter, Nagy, Orsolya, Bakonyi, Tamás, Csonka, Nikolett, Kaposi, Magdolna, Koroknai, Anita, Szomor, Katalin, Rigó, Zita, Molnár, Zsuzsanna, Dánielisz, Ágnes, Takács, Mária
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636212/
https://www.ncbi.nlm.nih.gov/pubmed/31311619
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.28.1900038
Descripción
Sumario:BACKGROUND: During the 2018 WNV transmission season, similarly to other endemic areas in Europe, a large number of human West Nile virus (WNV) infections were reported in Hungary. AIMS: We summarise the epidemiological and laboratory findings of the 2018 transmission season and expand experiences in flavivirus differential diagnostics. METHODS: Every patient with clinical suspicion of acute WNV infection was in parallel tested for WNV, tick-borne encephalitis virus and Usutu virus (USUV) by serological methods. Sera, whole blood and urine samples were also tested for the presence of viral nucleic acid. RESULTS: Until the end of December 2018, 215 locally acquired and 10 imported human WNV infections were notified in Hungary. All reported cases were symptomatic; most of them exhibited neurological symptoms. In a large proportion of tested individuals, whole blood was the most appropriate sample type for viral nucleic acid detection, but because whole blood samples were not always available, testing of urine samples also extended diagnostic possibilities. In addition, the first human USUV infection was confirmed in 2018 in a patient with aseptic meningitis. Serological cross-reactions with WNV in different serological assays were experienced, but subsequent molecular biological testing and sequence analysis identified Europe lineage 2 USUV infection. CONCLUSION: Careful interpretation and simultaneous application of different laboratory methods are necessary to avoid misdiagnosis of human USUV cases. Expansion of the laboratory-confirmed case definition criteria for detection of viral RNA in any clinical specimens to include urine samples could increase diagnostic sensitivity.